- Home
- SILC vs ARCT Comparison
SILC vs ARCT Comparison
Compare SILC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SILC | ARCT |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 259.1M | 208.3M |
| IPO Year | 2002 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SILC | ARCT |
|---|---|---|
| Price | $46.60 | $7.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | 134.6K | ★ 345.9K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $12.28 | $12.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.34 | $5.85 |
| 52 Week High | $52.58 | $24.14 |
Technical Indicators
Market Signals| Indicator | SILC | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 50.54 |
| Support Level | $16.31 | $6.79 |
| Resistance Level | $50.75 | $7.94 |
| Average True Range (ATR) | 4.55 | 0.42 |
| MACD | -0.13 | 0.04 |
| Stochastic Oscillator | 77.76 | 55.41 |
Price Performance
Historical ComparisonAbout SILC Silicom Ltd
Silicom Ltd is engaged in designing, manufacturing, marketing, and supporting high-performance networking and data infrastructure solutions for a broad range of servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, Switches, Edge AI Solutions, Edge Networking Accessories, 4G 5G Products, FPGA-Based Cards, and Others. Its geographic areas are the USA, North America - other, Israel, Europe, and Asia-Pacific. It derives a majority of its revenue from the USA.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.